Bharat Biotech ropes in 13,000 volunteers for Covaxin phase-III trials
Covaxin is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).
Full Article
Bharat Biotech ropes in 13,000 volunteers for Covaxin phase-III trials
Hindu
0 shares
1 views
You might like
Related news coverage
Bhopal: Volunteers ready for second dose of Covaxin in human trials
DNA
Bharat Biotech has been given permission for conducting phase-3 human clinical trials of Covaxin from Drugs Controller General of..